Proposed Data Collections Submitted for Public Comment and Recommendations, 6570-6571 [E7-2309]

Download as PDF 6570 Federal Register / Vol. 72, No. 28 / Monday, February 12, 2007 / Notices sroberts on PROD1PC70 with NOTICES a completed property sale. The possibility of sellers or buyers using the MLS but bypassing brokerage services is already addressed effectively by the Respondent’s existing rules that do not distinguish between forms of listing contracts, and does not justify the series of exclusionary rules and policies adopted by MiRealSource. It is possible, of course, that a buyer of an Exclusive Agency Listing may make the purchase without using a selling broker, but this is true for traditional Exclusive Right to Sell Listings as well. IV. The Proposed Consent Order The proposed order is designed to ensure that the Respondent does not misuse its market power, while preserving the procompetitive incentives of members to contribute to the MLS. The proposed order prohibits MiRealSource from adopting or enforcing any rules or policies that deny or limit the ability of MLS members to enter into Exclusive Agency Listings, or any other lawful listing agreements, with sellers of properties. More specifically, the proposed order prohibits MiRealSource from preventing its members from offering or accepting Exclusive Agency Listings or other lawful listing agreements; cooperating with Listing Brokers or agents that offer or accept Exclusive Agency Listings or other lawful listing agreements; publishing Exclusive Agency Listings or other lawful listing agreements on the MLS and approved Web sites; publishing their information concerning listings on public real estate Web sites, including but not limited to https:// www.FSBO.com; requiring members to have a physical office; and offering unbundled real estate brokerage services, including but not limited to requiring MiRealSource Shareholders to provide a minimum set of real estate brokerage services. The proposed order also prohibits MiRealSource from denying or restricting the services of the MLS to Exclusive Agency Listings or other lawful listings in any way that such services of the MLS are not denied or restricted to Exclusive Right to Sell Listings; or treating Exclusive Agency Listings, or any other lawful listings, in a less advantageous manner than Exclusive Right to Sell Listings, including but not limited to, any policy, rule or practice pertaining to the transmission, downloading, or displaying of information pertaining to such listings. In addition to these substantive provisions, the proposed order states that, within forty-five days after it becomes final, Respondent shall have VerDate Aug<31>2005 19:52 Feb 09, 2007 Jkt 211001 conformed its rules to the substantive provisions of the order. Respondent is further required to notify its members of the applicable order through its usual business communications and its Web site. The proposed order requires notification to the Commission of changes in the respondent’s structure, and periodic filings of written reports concerning compliance. The relief in the proposed consent order ensures that the Respondent cannot revert to the old rules or policies, or engage in future variations of the challenged conduct. The proposed order applies to MiRealSource and entities it owns or controls, including its respective MLS and any affiliated Web site it operates. The order does not prohibit members, or other independent persons or entities that receive listing information from Respondent, from making independent decisions concerning the use or display of such listing information on member or third-party Web sites, consistent with any contractual obligations to Respondent. The proposed order will expire in 10 years. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E7–2305 Filed 2–9–07; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-07–0527] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Joan F. Karr, CDC Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Human Exposure to Cyanobacterial Toxins in Water (OMB No. 0920– 0527)—Reinstatement—National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention (CDC). Background and Brief Description Cyanobacteria (blue-green algae) can be found in terrestrial, fresh, brackish, or marine water environments. Some species of cyanobacteria produce toxins that may cause acute or chronic illnesses (including neurotoxicity, hepatotoxicity, and skin irritation) in humans and animals (including other mammals, fish, and birds). A number of human health effects, including gastroenteritis, respiratory effects, skin irritations, allergic responses, and liver damage, are associated with the ingestion of or contact with water containing cyanobacterial blooms. Although the balance of evidence, in conjunction with data from laboratory animal research, suggests that cyanobacterial toxins are responsible for a range of human health effects, there have been few epidemiologic studies of this association. During August 2006, we conducted our first study to assess exposure to microcystins in recreational waters with a bloom of Microcystis aeruginosa. We recruited 104 people who gave informed consent to participate. Ninety seven people did their recreational activities on Lake 1, which had a confirmed M. aeruginosa bloom, and 7 others did their activities on Lake 2, which had no bloom. Study participants completed a pre-activity questionnaire, a postactivity questionnaire, provided a 10-ml blood sample, and completed a telephone symptom survey 7–10 days after exposure. The concentrations of microcystins in Lake 1 ranged from 2 to 5 ug/L and in Lake 2 were all below the limit of detection (LOD). When we designed the study, we calculated that a person exposed to recreationallygenerated aerosols from water containing 10 ug/L of microcystins should have levels of microcystins in E:\FR\FM\12FEN1.SGM 12FEN1 Federal Register / Vol. 72, No. 28 / Monday, February 12, 2007 / Notices their blood. However, the microcystin concentrations in Lake 2 were below the LOD and in Lake 1 were actually 2ug/ L to 5ug/L, much lower than we anticipated based on data from the previous week. Thus, the recreational exposures were not likely high enough for us to quantify microcystins in blood and the serum samples were all below the LOD for microcystins. For the new data collection, we will recruit 100 study participants who are at risk for swallowing water or inhaling spray (i.e., water skiers, jet skiers, people sailing small boats) and who 6571 complete a telephone symptom survey 8–10 days after doing study activities. The purpose of the new data collection is to continue assessing the public health impact of exposure to the cyanobacterial toxins, microcystins, during recreational activities. We will examine the extent of human exposure to microcystins present in recreational waters and associated aerosols and whether serum levels of microcystins can be used as a biomarker of exposure. There is no cost to the respondents other than their time. would normally be doing these activities, even in the presence of a bloom. We may recruit people who train for organized swimming events (e.g., triathlons) in lakes. In addition, we will recruit 50 study participants from lakes with no blooms as a comparison group to assess the health effects associated with recreational activities on ‘‘clean’’ lakes. Study participants will be asked to sign a consent form, complete a symptom survey before and after doing their recreational water activities, provide one 10-ml whole blood sample after their recreational activities, and ESTIMATE OF ANNUALIZED BURDEN HOURS Forms Number of respondents Number of responses per respondent Average burden per response (in hours) Screening Questionnaire ................................................................................. Pre-exposure Questionnaire ............................................................................ Post-exposure Questionnaire .......................................................................... 10-day post exposure Questionnaire .............................................................. Total .......................................................................................................... 188 150 150 150 ........................ 1 1 1 1 ........................ 10/60 10/60 10/60 10/60 ........................ Dated: February 6, 2007. Joan F. Karr, Acting Reports Clearance Officer. Centers for Disease Control and Prevention. [FR Doc. E7–2309 Filed 2–9–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-07–0630] sroberts on PROD1PC70 with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Joan Karr, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including VerDate Aug<31>2005 19:52 Feb 09, 2007 Jkt 211001 whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Work Organization Predictors of Depression in Women—Extension—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description Depression is a costly and debilitating occupational health problem. Research has indicated that the costs to an organization of treatment for depression can rival those for heart disease, and both major depressive disorder and forms of minor depression have been found to be associated with more disability days than other types of health diagnoses. This may be of particular relevance for working women. Various national and international studies indicate that women in developed countries experience depression at up to twice the rate of men. Studies that have examined this gender difference have focused on PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Total burden hours 31 25 25 25 106 social, personality, and genetic explanations while few have explored factors in the workplace that may contribute to the gender differential. Examples of workplace factors that may contribute to depression among women include: Additive workplace and home responsibilities, lack of control and authority, and low paying and low status jobs. Additionally, women are much more likely to face various types of discrimination in the workplace than men, ranging from harassment to inequalities in hiring and promotional opportunities, and these types of stressors have been strongly linked with psychological distress and other negative health outcomes. On the positive side, organizations that are judged by their employees to value diversity and employee development engender lower levels of employee stress, and those that enforce policies against discrimination have more committed employees. Such organizational practices and policies may be beneficial for employee mental health, particularly the mental health of women. This research focuses on the following questions: (1) Which work organization factors are most predictive of depression in women, and (2) are there measurable work organization factors that confer protection against depression in women employees? The research uses repeated measures, prospective design with data collection at three points (baseline and 1-year and 2-year follow-ups). A 45-minute survey E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 72, Number 28 (Monday, February 12, 2007)]
[Notices]
[Pages 6570-6571]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-2309]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-07-0527]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Joan F. Karr, CDC Reports Clearance Officer, 1600 
Clifton Road, MS-D74, Atlanta, GA 30333 or send an email to 
omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Human Exposure to Cyanobacterial Toxins in Water (OMB No. 0920-
0527)--Reinstatement--National Center for Environmental Health (NCEH), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Cyanobacteria (blue-green algae) can be found in terrestrial, 
fresh, brackish, or marine water environments. Some species of 
cyanobacteria produce toxins that may cause acute or chronic illnesses 
(including neurotoxicity, hepatotoxicity, and skin irritation) in 
humans and animals (including other mammals, fish, and birds). A number 
of human health effects, including gastroenteritis, respiratory 
effects, skin irritations, allergic responses, and liver damage, are 
associated with the ingestion of or contact with water containing 
cyanobacterial blooms. Although the balance of evidence, in conjunction 
with data from laboratory animal research, suggests that cyanobacterial 
toxins are responsible for a range of human health effects, there have 
been few epidemiologic studies of this association.
    During August 2006, we conducted our first study to assess exposure 
to microcystins in recreational waters with a bloom of Microcystis 
aeruginosa. We recruited 104 people who gave informed consent to 
participate. Ninety seven people did their recreational activities on 
Lake 1, which had a confirmed M. aeruginosa bloom, and 7 others did 
their activities on Lake 2, which had no bloom. Study participants 
completed a pre-activity questionnaire, a post-activity questionnaire, 
provided a 10-ml blood sample, and completed a telephone symptom survey 
7-10 days after exposure. The concentrations of microcystins in Lake 1 
ranged from 2 to 5 ug/L and in Lake 2 were all below the limit of 
detection (LOD). When we designed the study, we calculated that a 
person exposed to recreationally-generated aerosols from water 
containing 10 ug/L of microcystins should have levels of microcystins 
in

[[Page 6571]]

their blood. However, the microcystin concentrations in Lake 2 were 
below the LOD and in Lake 1 were actually 2ug/L to 5ug/L, much lower 
than we anticipated based on data from the previous week. Thus, the 
recreational exposures were not likely high enough for us to quantify 
microcystins in blood and the serum samples were all below the LOD for 
microcystins.
    For the new data collection, we will recruit 100 study participants 
who are at risk for swallowing water or inhaling spray (i.e., water 
skiers, jet skiers, people sailing small boats) and who would normally 
be doing these activities, even in the presence of a bloom. We may 
recruit people who train for organized swimming events (e.g., 
triathlons) in lakes. In addition, we will recruit 50 study 
participants from lakes with no blooms as a comparison group to assess 
the health effects associated with recreational activities on ``clean'' 
lakes. Study participants will be asked to sign a consent form, 
complete a symptom survey before and after doing their recreational 
water activities, provide one 10-ml whole blood sample after their 
recreational activities, and complete a telephone symptom survey 8-10 
days after doing study activities.
    The purpose of the new data collection is to continue assessing the 
public health impact of exposure to the cyanobacterial toxins, 
microcystins, during recreational activities. We will examine the 
extent of human exposure to microcystins present in recreational waters 
and associated aerosols and whether serum levels of microcystins can be 
used as a biomarker of exposure.
    There is no cost to the respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                      Forms                         respondents   responses  per   response (in        hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Screening Questionnaire.........................             188               1           10/60              31
Pre-exposure Questionnaire......................             150               1           10/60              25
Post-exposure Questionnaire.....................             150               1           10/60              25
10-day post exposure Questionnaire..............             150               1           10/60              25
    Total.......................................  ..............  ..............  ..............             106
----------------------------------------------------------------------------------------------------------------


    Dated: February 6, 2007.
Joan F. Karr,
Acting Reports Clearance Officer. Centers for Disease Control and 
Prevention.
 [FR Doc. E7-2309 Filed 2-9-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.